Clinical Data of Patients With PBL
Patient No. . | Sex/Age . | HIV . | Symptoms . | Primary Tumor . | Jaw Bone Infiltration . | Other Organs Involved at Diagnosis . | Bone Marrow Involvement . | Stage at Diagnosis . | Involvement of Organs During Evolution . | Therapy . | Evolution (in months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
. | (yr) . | (risk group) . | . | . | . | . | . | . | . | . | . |
1 | M/34 | +(unknown) | B | Floor of the mouth | No | Retroperitoneum, thigh | No | IVB | PC | Dead, 6 | |
2 | M/37 | +(HS) | B | Gingiva | No | None | No | IBE | Lymph nodes, maxillary sinus | PC | Dead, 11 |
3 | M/33 | +(IVDA) | A | Gingiva | No | None | No | IAE | RT | Lost at follow-up | |
4 | M/48 | +(HS) | A | Hard palate | No | None | No | IAE | RT | Dead,* 16 | |
5 | F/75 | − | A | Gingiva | No | None | No | IAE | RT | Dead,* 3 | |
6 | M/41 | +(HS) | A | Gingiva | No | None | No | IAE | PC + RT | Dead,* 6 | |
7 | M/43 | +(HS) | B | Palate | No | None | No | IBE | Refused | Lost at follow-up | |
8 | F/33 | +(IVDA) | B | Floor of the mouth | No | Stomach | No | IVB | PC | Dead, 1 | |
9 | M/42 | +(HS) | A | Gingiva | No | None | No | IAE | Thigh, arm | PC, RT | Dead, 5 |
10 | M/55 | +(HS) | A | Gingiva | No | None | No | IAE | Abdominal lymph nodes | PC | Alive, 18 |
11 | M/27 | +(HS) | A | Gingiva | No | None | No | IAE | PC | Unknown | |
12 | M/31 | +(BT, HS) | B | Palate | Yes | Abdomen, thigh, bones | Yes | IVB | PC | Lost at follow-up | |
13 | M/39 | +(HS) | A | Tonsil | No | None | No | IAE | CNS | PC + RT | Dead, 6 |
14 | M/49 | +(HS) | A | Floor of the mouth | No | Bone marrow | Yes (5% tumor cells) | IVA | Unknown | Lost at | |
follow-up | |||||||||||
15 | M/39 | +(HS) | A | Gingiva | No | None | No | IAE | RT | Alive, 8 | |
16 | M/32 | +(HS) | B | Submandibular region | No | Abdomen | No | IVB | PC + RT | Dead,* 12 |
Patient No. . | Sex/Age . | HIV . | Symptoms . | Primary Tumor . | Jaw Bone Infiltration . | Other Organs Involved at Diagnosis . | Bone Marrow Involvement . | Stage at Diagnosis . | Involvement of Organs During Evolution . | Therapy . | Evolution (in months) . |
---|---|---|---|---|---|---|---|---|---|---|---|
. | (yr) . | (risk group) . | . | . | . | . | . | . | . | . | . |
1 | M/34 | +(unknown) | B | Floor of the mouth | No | Retroperitoneum, thigh | No | IVB | PC | Dead, 6 | |
2 | M/37 | +(HS) | B | Gingiva | No | None | No | IBE | Lymph nodes, maxillary sinus | PC | Dead, 11 |
3 | M/33 | +(IVDA) | A | Gingiva | No | None | No | IAE | RT | Lost at follow-up | |
4 | M/48 | +(HS) | A | Hard palate | No | None | No | IAE | RT | Dead,* 16 | |
5 | F/75 | − | A | Gingiva | No | None | No | IAE | RT | Dead,* 3 | |
6 | M/41 | +(HS) | A | Gingiva | No | None | No | IAE | PC + RT | Dead,* 6 | |
7 | M/43 | +(HS) | B | Palate | No | None | No | IBE | Refused | Lost at follow-up | |
8 | F/33 | +(IVDA) | B | Floor of the mouth | No | Stomach | No | IVB | PC | Dead, 1 | |
9 | M/42 | +(HS) | A | Gingiva | No | None | No | IAE | Thigh, arm | PC, RT | Dead, 5 |
10 | M/55 | +(HS) | A | Gingiva | No | None | No | IAE | Abdominal lymph nodes | PC | Alive, 18 |
11 | M/27 | +(HS) | A | Gingiva | No | None | No | IAE | PC | Unknown | |
12 | M/31 | +(BT, HS) | B | Palate | Yes | Abdomen, thigh, bones | Yes | IVB | PC | Lost at follow-up | |
13 | M/39 | +(HS) | A | Tonsil | No | None | No | IAE | CNS | PC + RT | Dead, 6 |
14 | M/49 | +(HS) | A | Floor of the mouth | No | Bone marrow | Yes (5% tumor cells) | IVA | Unknown | Lost at | |
follow-up | |||||||||||
15 | M/39 | +(HS) | A | Gingiva | No | None | No | IAE | RT | Alive, 8 | |
16 | M/32 | +(HS) | B | Submandibular region | No | Abdomen | No | IVB | PC + RT | Dead,* 12 |
Abbreviations: PC, polychemotherapy; HS, homosexual; IVDA, intravenous drug abuse; RT, radiotherapy; BT, blood transfusion; CNS, central nervous system.
Dead of unrelated or multiple causes.